Please upgrade your browser.
Surgical removal of the kidney -- a procedure known as nephrectomy -- improves survival in patients with locally advanced renal cell carcinoma, the most common form of kidney cancer.
Comments: I am a kidney cancer survivor and my wife is abreast cancer survivor. This cancer kills so many people usually over age 60.
In 2006, Mrs. Alexander received the Minerva Award, created by Maria Shriver to honor women who have achieved extraordinary things. Other recipients include astronaut Sally Ride and House Speaker Nancy Pelosi.
A cluster of families in Swansea have had applications for Sutent and other new kidney cancer drugs refused by the citys local health board officials.
A prototype device employs the same magnetic phenomenon used to write data to computer hard drives.
"We made a very small nanosensor that can detect cancer-causing molecules or important therapeutic drugs inside of a single living cell," said Michael Strano of Massachusetts Institute of Technology in Cambridge, who worked on the study.
The move is a major victory for campaigners, patients and cancer specialists. They had described Nice's refusal to approve the drugs - which cost up to £70,000 a year per patient - as unfair, inhumane and condemning patients to an unnecessarily early death.
The improvements are due to gains against some leading cancers -- prostate, colorectal, breast and, for men, lung cancer -- but numerous other types still are on the rise, including melanoma and kidney cancer, the report said.
Medarex Announces Initiation of Phase 1b Clinical Development Program with MDX-1106 for the Treatment of Cancer
Medarex, Inc. (Nasdaq: MEDX) today announced it has initiated a Phase 1b clinical trial for MDX-1106 (ONO-4538: development code of Ono Pharmaceutical Co., Ltd.), a fully human anti-PD-1 antibody for the treatment of cancer. Studies suggest that the PD-1 signaling pathway may play an important role in tumor evasion and escape from host immune responses and may also promote the persistence of certain chronic viral infections.
Biotechnology company Antigenics Inc (AGEN.O: Quote, Profile, Research, Stock Buzz) said on Monday that its Oncophage vaccine extended survival in a small study of patients with brain cancer.
|Powered by NeonCRM|